Skip to main content

Dr Reddy’s Labs Recalls 35,000 Tubes of Skin Infection Cream from US

Penelitian - Dr Reddy’s Laboratories’ US arm is recalling over 35,000 tubes of Nystatin and Triamcinolone Acetonide cream on account of failed stability specifications, USFDA said.

As per the US health regulator’s Enforcement Report, Dr Reddy’s Labs Inc is recalling 35,020 tubes of Nystatin and Triamcinolone Acetonide Cream, USP, 1,00,000 units/gm and 1 mg/gm from the American market.

Penelitian Dr Reddy’s Labs recalls 35,000 tubes of skin infection cream from US

The recall is on account of “failed stability specifications, an out of specification result was observed for the test parameter : composition of Nystatin during stability testing,” it added.

The cream is used for treatment of cutaneous candidiasis, a skin infection. The voluntary ongoing nationwide recall is a class II recall, United States Food and Drug Administration (USFDA) said.

As per USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.



Gambar Tiga Dimensi Struktur Detail Virus Zika Resmi Terbit

Alat Batu Di Sulawesi Cahaya Homo floresiensis Berasal

An Evolutionarily-conserved Wnt3/β-catenin/Sp5 Feedback Loop Restricts Head Organizer Activity in Hydra

Teori Panspermia, Distribusi Kehidupan Seperti Epidemi

Genom Komplit Menghidupkan Kembali Mammoth Woolly